Navigation Links
Nuclear waste requires cradle-to-grave strategy
Date:8/14/2011

Los Angeles, CA (July 1, 2011) After Fukushima, it is now imperative to redefine what makes a successful nuclear power program - from cradle to grave. If nuclear waste management is not thought out from the beginning, the public in many countries will reject nuclear power as an energy choice, according to research that appears today in the Bulletin of the Atomic Scientists, published by SAGE.

According to Allison Macfarlane, associate professor of environmental science and policy at George Mason University, and a member of the Blue Ribbon Commission on America's Nuclear Future, coming up with storage solutions for nuclear waste continues to be a last-minute decision in a number of countries besides Japan. It is surprisingly common for reactor sites to be overburdened with spent fuel with no clear disposal plan. In South Korea, for example, storage at the nation's four nuclear plants is filling up, leading to a potential storage crisis within the next decade.

The United Arab Emirates broke ground for the first of four nuclear reactors on March 14, 2011 but has not prioritized storage. Hans Blix, former head of the International Atomic Energy Agency and current chairman of the UAE's International Advisory Board, noted: "The question of a final disposal plan is still open and more attention should be spent on deciding what to do."

Some very low level nuclear wastes can go into landfill-type settings. But low level wastes, composed of low concentrations of long-lived radionuclides and higher concentrations of short-lived ones, must remain sequestered for a few hundred years in specially engineered subsurface facilities. Intermediate and high level wastes require disposal hundreds of meters below the ground for thousands or even hundreds of thousands of years to ensure public safety. Intermediate wastes contain high concentrations of long-lived radionuclides, as do high level wastes, including spent nuclear fuel and fuel reprocess
'/>"/>

Contact: Jayne Fairley
jayne.fairley@sagepub.co.uk
44-207-324-8719
SAGE Publications
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology technology :

1. Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
2. Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine
3. Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost
4. Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost
5. Nuclear fusion research key to advancing computer chips
6. Researchers create smaller and more efficient nuclear battery
7. Strategic cooperation sets the scene for geological disposal of nuclear waste in Europe
8. Safer nuclear reactors could result from Los Alamos research
9. Findings show promise for nuclear fusion test reactors
10. Berkeley scientists pioneer nanoscale nuclear materials testing capability
11. International Isotopes Inc. Announces Successful International Standards Certification for Manufacture of Its Nuclear Medicine Products and Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... PuraMed BioScience ® , Inc., (OTCBB: ... (OTC) medicinal and healthcare products, announced that Ludlow ... based on low market capitalization valuation. ... Product to Treat Migraine Headaches , Clinical ... , Currently Available Nationwide at Walgreen,s and ...
(Date:5/23/2013)... , May 23, 2013  Saddleback Memorial Medical ... recently became the first hospital on the West Coast ... This new surgical option provides women with a state-of-the-art, ... Marc Winter , M.D., a highly ... surgeon and medical director of minimally invasive surgery at ...
(Date:5/23/2013)... Md. , May 23, 2013 Northwest ... biotechnology company developing DCVax ® personalized immune therapies ... use its exhibit at this year,s American Society Of ... to highlight its leadership role in immune therapy.  ... The ASCO annual meeting is the pre-eminent conference focused ...
(Date:5/23/2013)... , May 23, 2013 Pusan ... Inc., a private biotherapeutics and contract research company ... products for cancer, announced today a publication reporting ... treated with the oncolytic and immunotherapeutic vaccinia JX-594 ... research was published in the May 15 th ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3
... Inc. (TSX: ONC, NASDAQ: ONCY ) ("Oncolytics") ... U.S. Patent, # 7,582,289, entitled "Viruses for the Treatment ... of using modified parapoxvirus orf virus to treat Ras-mediated ... portfolio regarding oncolytic viruses, in addition to reovirus, that ...
... WILMINGTON, Delaware, September 1 According ... (2009-2014),published by MarketsandMarkets ( http://www.marketsandmarkets.com ), the,global autoimmune ... 2014, with an estimated CAGR of 12.7% from 2009 ... for nearly 42% of the total revenues. , ...
... ... of continuous research, experiments and trials have given Centre for Jatropha Promotion ... alternative feedstock for biodiesel. After having a number of successful field trials ... source for Bio- Diesel industry of future and is happy to announce ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Announces Issuance of 32nd U.S. Patent 2MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014 2MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014 3MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014 4Derris Indica is CJP's New Nonfood Biodiesel Crop for Profitable Sustainability 2Derris Indica is CJP's New Nonfood Biodiesel Crop for Profitable Sustainability 3
(Date:5/23/2013)... be the world,s most popular fruit, can be made ... purple GM varieties. , "Working with GM tomatoes ... addition of a specific compound, allows us to pinpoint ... Cathie Martin from the John Innes Centre. , The ... flavour, health and shelf life characteristics because even higher ...
(Date:5/23/2013)... discovering the new mechanism by which estrogen suppresses lipid ... a potential new approach toward treating certain liver diseases. ... colleagues believe they are changing long-held views in the ... of the journal Science Signaling . , "The ... has been that only receptors located in the nucleus ...
(Date:5/23/2013)... 23, 2013) A new report from the Institute ... pupils engage in at least 60 minutes of vigorous ... No more than half of American youth meet current ... or moderate intensity physical activity daily, according to the ... are in school for nearly half of their waking ...
Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide students with daily physical activity, IOM recommends 2
... of obesity among South Asians to be recalculated has been ... A team from the University,s Departments of Health Sciences and ... which South Asians should be classed as obese to be ... One , a journal of the Public Library of Science. ...
... three-person start-up may well be on its way to ... team of young Dutch scientists pushing disruptive biotech innovations ... attention of some key investors and demonstrating the added ... with the Eurostars funding programme leading the way. ...
... Spanish . CHICAGO -- A 10-year ... infants with high hemoglobin levels who received iron fortified infant ... in Santiago, Chile, was published online today ahead of print ... and raises questions about the optimal amount of iron in ...
Cached Biology News:New research calls for lower limit to be set for South Asian obesity level 2Biotech start-up brings DNA-sequencing to the medical market 2Biotech start-up brings DNA-sequencing to the medical market 3Routine iron fortification of infant formula linked to poorer development 2Routine iron fortification of infant formula linked to poorer development 3
Mouse monoclonal antibody raised against a partial recombinant CALCOCO2. NCBI Entrez Gene ID = CALCOCO2...
Mouse polyclonal antibody raised against a partial recombinant KCTD13. NCBI Entrez Gene ID = 253980...
... pLivSelect is a direct antibiotic-based selection system ... on colony survival, eliminating the need for ... process provides close to 100% accuracy in ... platform for robot colony picking. This ...
Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Alpha-2-AP). [Source:Uniprot/SWISSPROT;Acc:P08697] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: